The Serotonin Theory of Depression: A Systematic Umbrella Review of the Evidence.

Focus (American Psychiatric Publishing) Pub Date : 2026-04-01 Epub Date: 2026-04-04 DOI:10.1176/appi.focus.26024112
Joanna Moncrieff, Ruth E Cooper, Tom Stockmann, Simone Amendola, Michael P Hengartner, Mark A Horowitz
{"title":"The Serotonin Theory of Depression: A Systematic Umbrella Review of the Evidence.","authors":"Joanna Moncrieff, Ruth E Cooper, Tom Stockmann, Simone Amendola, Michael P Hengartner, Mark A Horowitz","doi":"10.1176/appi.focus.26024112","DOIUrl":null,"url":null,"abstract":"<p><p>The serotonin hypothesis of depression is still influential. We aimed to synthesise and evaluate evidence on whether depression is associated with lowered serotonin concentration or activity in a systematic umbrella review of the principal relevant areas of research. PubMed, EMBASE and PsycINFO were searched using terms appropriate to each area of research, from their inception until December 2020. Systematic reviews, meta-analyses and large data-set analyses in the following areas were identified: serotonin and serotonin metabolite, 5-HIAA, concentrations in body fluids; serotonin 5-HT<sub>1A</sub> receptor binding; serotonin transporter (SERT) levels measured by imaging or at post-mortem; tryptophan depletion studies; SERT gene associations and SERT geneenvironment interactions. Studies of depression associated with physical conditions and specific subtypes of depression (e.g. bipolar depression) were excluded. Two independent reviewers extracted the data and assessed the quality of included studies using the AMSTAR-2, an adapted AMSTAR-2, or the STREGA for a large genetic study. The certainty of study results was assessed using a modified version of the GRADE. We did not synthesise results of individual meta-analyses because they included overlapping studies. The review was registered with PROSPERO (CRD42020207203). 17 studies were included: 12 systematic reviews and meta-analyses, 1 collaborative meta-analysis, 1 meta-analysis of large cohort studies, 1 systematic review and narrative synthesis, 1 genetic association study and 1 umbrella review. Quality of reviews was variable with some genetic studies of high quality. Two meta-analyses of overlapping studies examining the serotonin metabolite, 5-HIAA, showed no association with depression (largest <i>n</i> = 1002). One meta-analysis of cohort studies of plasma serotonin showed no relationship with depression, and evidence that lowered serotonin concentration was associated with antidepressant use (<i>n</i> = 1869). Two meta-analyses of overlapping studies examining the 5-HT<sub>1A</sub> receptor (largest <i>n</i> = 561), and three meta-analyses of overlapping studies examining SERT binding (largest <i>n</i> = 1845) showed weak and inconsistent evidence of reduced binding in some areas, which would be consistent with increased synaptic availability of serotonin in people with depression, if this was the original, causal abnormaly. However, effects of prior antidepressant use were not reliably excluded. One meta-analysis of tryptophan depletion studies found no effect in most healthy volunteers (<i>n</i> = 566), but weak evidence of an effect in those with a family history of depression (<i>n</i> = 75). Another systematic review (<i>n</i> = 342) and a sample of ten subsequent studies (<i>n</i> = 407) found no effect in volunteers. No systematic review of tryptophan depletion studies has been performed since 2007. The two largest and highest quality studies of the SERT gene, one genetic association study (<i>n</i> = 115,257) and one collaborative meta-analysis (<i>n</i> = 43,165), revealed no evidence of an association with depression, or of an interaction between genotype, stress and depression. The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations. Some evidence was consistent with the possibility that long-term antidepressant use reduces serotonin concentration. Appeared originally in <i>Mol Psychiatry</i> 2023; 28:3243-3256.</p>","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"24 2","pages":"236-251"},"PeriodicalIF":0.0000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13337345/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Focus (American Psychiatric Publishing)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1176/appi.focus.26024112","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The serotonin hypothesis of depression is still influential. We aimed to synthesise and evaluate evidence on whether depression is associated with lowered serotonin concentration or activity in a systematic umbrella review of the principal relevant areas of research. PubMed, EMBASE and PsycINFO were searched using terms appropriate to each area of research, from their inception until December 2020. Systematic reviews, meta-analyses and large data-set analyses in the following areas were identified: serotonin and serotonin metabolite, 5-HIAA, concentrations in body fluids; serotonin 5-HT1A receptor binding; serotonin transporter (SERT) levels measured by imaging or at post-mortem; tryptophan depletion studies; SERT gene associations and SERT geneenvironment interactions. Studies of depression associated with physical conditions and specific subtypes of depression (e.g. bipolar depression) were excluded. Two independent reviewers extracted the data and assessed the quality of included studies using the AMSTAR-2, an adapted AMSTAR-2, or the STREGA for a large genetic study. The certainty of study results was assessed using a modified version of the GRADE. We did not synthesise results of individual meta-analyses because they included overlapping studies. The review was registered with PROSPERO (CRD42020207203). 17 studies were included: 12 systematic reviews and meta-analyses, 1 collaborative meta-analysis, 1 meta-analysis of large cohort studies, 1 systematic review and narrative synthesis, 1 genetic association study and 1 umbrella review. Quality of reviews was variable with some genetic studies of high quality. Two meta-analyses of overlapping studies examining the serotonin metabolite, 5-HIAA, showed no association with depression (largest n = 1002). One meta-analysis of cohort studies of plasma serotonin showed no relationship with depression, and evidence that lowered serotonin concentration was associated with antidepressant use (n = 1869). Two meta-analyses of overlapping studies examining the 5-HT1A receptor (largest n = 561), and three meta-analyses of overlapping studies examining SERT binding (largest n = 1845) showed weak and inconsistent evidence of reduced binding in some areas, which would be consistent with increased synaptic availability of serotonin in people with depression, if this was the original, causal abnormaly. However, effects of prior antidepressant use were not reliably excluded. One meta-analysis of tryptophan depletion studies found no effect in most healthy volunteers (n = 566), but weak evidence of an effect in those with a family history of depression (n = 75). Another systematic review (n = 342) and a sample of ten subsequent studies (n = 407) found no effect in volunteers. No systematic review of tryptophan depletion studies has been performed since 2007. The two largest and highest quality studies of the SERT gene, one genetic association study (n = 115,257) and one collaborative meta-analysis (n = 43,165), revealed no evidence of an association with depression, or of an interaction between genotype, stress and depression. The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations. Some evidence was consistent with the possibility that long-term antidepressant use reduces serotonin concentration. Appeared originally in Mol Psychiatry 2023; 28:3243-3256.

抑郁症的血清素理论:一个系统的证据综述。
抑郁症的血清素假说仍然有影响。我们旨在综合和评估抑郁症是否与血清素浓度或活性降低有关的证据,对主要相关研究领域进行系统的综合综述。PubMed, EMBASE和PsycINFO使用适合于每个研究领域的术语进行搜索,从它们成立到2020年12月。系统评价、荟萃分析和大型数据集分析确定了以下领域:血清素和血清素代谢物,5-HIAA,体液中的浓度;5-羟色胺5-HT1A受体结合;5 -羟色胺转运体(SERT)水平通过成像或在死后测量;色氨酸耗竭研究;SERT基因关联及SERT基因与环境相互作用。排除了与身体状况和特定抑郁症亚型(如双相抑郁症)相关的抑郁症研究。两名独立的审稿人提取了数据,并使用AMSTAR-2、改编的AMSTAR-2或用于大型遗传研究的STREGA评估了纳入研究的质量。研究结果的确定性采用改良版GRADE进行评估。我们没有综合单个荟萃分析的结果,因为它们包括重叠的研究。该审查已在PROSPERO注册(CRD42020207203)。纳入17项研究:12项系统综述和荟萃分析、1项协作荟萃分析、1项大队列研究荟萃分析、1项系统综述和叙事综合、1项遗传关联研究和1项总括性综述。综述的质量是可变的,一些高质量的遗传研究。两项重叠研究的荟萃分析检查了血清素代谢物5-HIAA,显示与抑郁症没有关联(最大n = 1002)。一项对血浆血清素队列研究的荟萃分析显示,血清素浓度降低与抑郁症没有关系,有证据表明,血清素浓度降低与抗抑郁药的使用有关(n = 1869)。两项针对5-HT1A受体的重叠研究的荟萃分析(最大n = 561)和三项针对SERT结合的重叠研究的荟萃分析(最大n = 1845)显示,在某些区域结合减少的证据薄弱且不一致,如果这是最初的因果异常,这将与抑郁症患者突触中血清素可用性增加相一致。然而,先前使用抗抑郁药的影响并不能可靠地排除。一项对色氨酸消耗研究的荟萃分析发现,对大多数健康志愿者(n = 566)没有影响,但对那些有抑郁症家族史的人(n = 75)有微弱的影响。另一项系统综述(n = 342)和随后的10项研究样本(n = 407)发现,对志愿者没有影响。自2007年以来,没有对色氨酸耗竭研究进行系统回顾。两项规模最大、质量最高的SERT基因研究,一项遗传关联研究(n = 115,257)和一项协作荟萃分析(n = 43165),均未发现SERT基因与抑郁症相关的证据,也未发现基因型、压力和抑郁之间存在相互作用的证据。5 -羟色胺研究的主要领域没有提供一致的证据表明5 -羟色胺和抑郁症之间存在联系,也没有证据支持抑郁症是由5 -羟色胺活性或浓度降低引起的假设。一些证据与长期使用抗抑郁药降低血清素浓度的可能性一致。最早出现在Mol Psychiatry 2023;28:3243 - 3256。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书